Oculis appoints Dr. Bastian Dehmel as Chief Development Officer
LAUSANNE, Switzerland, Feb 8, 2022 – (ACN Newswire via SEAPRWire.com) – Oculis S.A. (“Oculis”), a late-stage biopharmaceutical company focused on developing transformative ophthalmic treatments to improve the sight and lives […]